Overview

A Study to Evaluate the Effects of Cannabis Based Medicine in Patients With Pain of Neurological Origin

Status:
Completed
Trial end date:
2002-08-01
Target enrollment:
Participant gender:
Summary
To investigate the ability of a cannabis based medicine extract to relieve chronic refractory pain of neurological origin.
Phase:
Phase 3
Details
Lead Sponsor:
GW Pharmaceuticals Ltd.
Treatments:
Dronabinol
Nabiximols